Walgreens Boots Alliance (NASDAQ:WBA) Reaches New 12-Month Low at $9.96

Walgreens Boots Alliance, Inc. (NASDAQ:WBA)’s stock price reached a new 52-week low on Tuesday . The stock traded as low as $9.96 and last traded at $10.03, with a volume of 5200047 shares changing hands. The stock had previously closed at $10.38.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. JPMorgan Chase & Co. lowered their target price on shares of Walgreens Boots Alliance from $30.00 to $20.00 and set an “overweight” rating on the stock in a report on Monday, July 1st. Truist Financial lowered their price objective on shares of Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating on the stock in a research note on Friday, June 28th. Royal Bank of Canada cut their target price on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research note on Tuesday, July 2nd. TD Cowen lowered their price target on Walgreens Boots Alliance from $35.00 to $22.00 and set a “buy” rating on the stock in a research report on Monday, July 1st. Finally, Barclays dropped their price objective on Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating on the stock in a research note on Tuesday, July 23rd. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the company. According to MarketBeat, Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus price target of $15.85.

Walgreens Boots Alliance Price Performance

The firm has a market capitalization of $7.93 billion, a price-to-earnings ratio of -1.39, a P/E/G ratio of 0.72 and a beta of 0.72. The company’s 50 day moving average is $11.70 and its 200 day moving average is $16.28. The company has a quick ratio of 0.31, a current ratio of 0.65 and a debt-to-equity ratio of 0.49.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The business had revenue of $36.40 billion for the quarter, compared to analyst estimates of $35.94 billion. During the same quarter in the previous year, the company earned $1.00 EPS. The business’s revenue for the quarter was up 2.8% on a year-over-year basis. On average, equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 2.87 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 12th. Shareholders of record on Wednesday, August 21st will be issued a $0.25 dividend. The ex-dividend date of this dividend is Wednesday, August 21st. This represents a $1.00 annualized dividend and a yield of 10.88%. Walgreens Boots Alliance’s dividend payout ratio is presently -14.84%.

Institutional Investors Weigh In On Walgreens Boots Alliance

Large investors have recently bought and sold shares of the company. Iron Horse Wealth Management LLC boosted its holdings in shares of Walgreens Boots Alliance by 162.5% in the 2nd quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 1,300 shares in the last quarter. Pineridge Advisors LLC bought a new position in Walgreens Boots Alliance in the fourth quarter valued at about $26,000. Blue Trust Inc. raised its stake in Walgreens Boots Alliance by 87.0% during the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 1,081 shares in the last quarter. Quest Partners LLC bought a new position in shares of Walgreens Boots Alliance in the fourth quarter worth about $30,000. Finally, Continuum Advisory LLC boosted its stake in shares of Walgreens Boots Alliance by 71.2% in the 2nd quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 1,020 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.